Hauer Jerome M 4
4 · Emergent BioSolutions Inc. · Filed Jan 24, 2018
Insider Transaction Report
Form 4
Hauer Jerome M
Director
Transactions
- Sale
Common Stock
2018-01-22$50.91/sh−5,152$262,292→ 18,645 total - Sale
Common Stock
2018-01-23$50.25/sh−2,577$129,494→ 16,068 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-01-22−5,152→ 0 totalExercise: $25.47Exp: 2022-01-21→ Common Stock (5,152 underlying) - Exercise/Conversion
Common Stock
2018-01-22$25.47/sh+5,152$131,221→ 23,797 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Hauer.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $51.25, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated.
- [F4]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.